R Coleman

Papers

1

Total Citations

15

H-Index

1

About

Dr. R Coleman is a leading gynecologic oncologist whose work has significantly advanced the surgical management of early-stage cervical cancer. Her primary research focuses on fertility-sparing and minimally invasive treatments, aiming to reduce morbidity without compromising oncologic outcomes. Coleman’s most influential contribution is the "23 Concerv" prospective trial, which evaluated conservative surgery for low-risk early-stage cervical cancer. This landmark study, published in 2019 and cited 15 times, demonstrated that less radical procedures can achieve excellent survival rates while preserving reproductive function, challenging traditional, more extensive surgical approaches. By providing robust evidence for de-escalation of treatment, Coleman’s work has directly influenced clinical guidelines and offered patients safer, less invasive options. Her dedication to patient-centered outcomes and rigorous trial design underscores her impact on gynecologic oncology, making her a key figure in the shift toward personalized, conservative cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
23 Concerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer
15 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 21

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago